targeted and armed next generation HSV-1716 (VIRTTU)

N/A

Report date: 2025/03/19 18:25:47

Base Information

Drug Nametargeted and armed next generation HSV-1716 (VIRTTU)
Drug Alias Namearmed oncolytic HSV therapy (VIRTTU Biologics)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirttu Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVirttu Biologics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A